Aehr's $92M AI Order Is Shipping-Why Investors May Still Be Underestimating the Repricing

The $41 million order matters because it changes the revenue story

The headline is the new order. The bigger story is what that order implies for near-term visibility.

A single award pushed second-half bookings above $92 million

Aehr just took in a $41 million follow-on production order from its lead hyperscale AI customer. That award pushed second-half bookings to more than $92 million with weeks still left in the quarter, and deliveries are expected to begin as fiscal 2027 starts on June 27, 2026. This is not a pilot or a sample deal; it is a production order tied to AI processor manufacturing.

Projected fiscal 2027 revenue now looks fundamentally different

Aehr now says record quarterly bookings and a $100.6 million effective backlog provide substantial visibility into $130 million to $150 million of projected fiscal 2027 revenue, versus $50.0 million in fiscal 2026. That is a much larger operating base than investors have recently modeled. For a small equipment maker, that kind of step-change in visibility is what usually drives a reset in expectations.

Why PLBI matters in AI production

The order size is important, but the product use case is more important.

Burn-in helps catch weak chips before deployment

Burn-in is essentially a factory stress test. Aehr's equipment runs chips at high power and temperature so weaker units fail on the production line instead of later in a live system. That is why the company says its tools help catch bad chips before they ship. For a customer using custom AI processors in data center training and inference AI workloads, that added protection matters because the chips are large, power-hungry, and expensive to replace.

Aehr covers two burn-in stages, not just one

Aehr is positioned to offer both wafer-level and package-level burn-in. That matters because different defects show up at different manufacturing stages. The new hyperscale award is specifically for package-level burn-in of custom AI processor ASICs, but the broader point is strategic: Aehr can cover more of the test path instead of serving just one moment in the flow.

Sonoma systems plus consumables can deepen the relationship

The latest award includes Sonoma™ high-power package-level test and burn-in systems, along with fully turnkey burn-in modules (BIMs) and device-specific sockets. Those sockets matter because they are the consumables required to configure the Sonoma systems for the customer's specific AI processor. In other words, revenue potential does not end when the tool is delivered.

Capacity expansion suggests management expects volume

Aehr also highlighted a newly upgraded contract manufacturer capable of 20+ additional Sonoma systems per month. That does not prove long-term demand by itself, but it does suggest management sees enough near-term volume demand to expand capacity before the story becomes obvious to everyone.

The market may still be applying the old SiC multiple

The old guidance backdrop was much lower

Aehr has long been judged partly through its silicon-carbide exposure. That framework was reinforced when the company reaffirmed H2 revenue guidance of $25M–$30M last April. Even so, that earlier frame still colors how some investors read the story.

The new guide points to a much larger year

The July update changed the conversation by pointing to $130 million to $150 million of projected fiscal 2027 revenue. That is not a small adjustment to the model. It is a shift from a tens-of-millions backdrop to a near-quarter-billion outlook. The core debate is whether the market is still pricing Aehr with the old SiC lens or starting to price the new AI visibility.

What would confirm or challenge the thesis

Skeptics are right to ask for follow-through. One large AI award does not settle the whole debate, and Aehr still serves multiple semiconductor markets both wafer-level and package-level burn-in. But the bull case is straightforward: if shipments begin on schedule and the new revenue range starts to look achievable, the stock has less room to stay priced as if the old guide still applied.

Watch these signals over the next few quarters: - Whether deliveries actually start as deliveries are expected to begin - Whether bookings continue to support the $130 million to $150 million fiscal 2027 outlook - Whether management keeps building on the follow-on production order rather than treating it as a one-time event